[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,2021,71(3):209-249. [2] 安澜,曾红梅,郑荣寿,等.2015年中国肝癌流行情况分析.中华肿瘤杂志,2019,41(10):721-727. [3] Chan YT, Zhang C, Wu J, et al. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer,2024,23(1):189. [4] Perivoliotis K, Ntellas P, Dadouli K, et al. Microvessel density (MVD) in patients with osteosarcoma: a systematic review and meta-analysis. Cancer Invest,2024,42(1):104-114. [5] Tian J, Liu Y, Zhang TL, et al. Clinical significance of LAG-3 on microvessel density in primary hepatocellular carcinoma. Indian J Pathol Microbiol,2022,65(3):581-588. [6] Goyal AV, Shukla S, Acharya S, et al. Correlation of microvessel density with histopathological parameters of carcinoma breast. Indian J Med Res,2023,158(4):417-422. [7] Garbino N, Brancato V, Salvatore M, et al. A systematic review on the role of the perfusion computed tomography in abdominal cancer. Dose Response,2021,19(4):15593258211056199. [8] Perl RM, Portugall J, Hinterleitner C, et al. Differences between CT-perfusion and biphasiccontrast-enhanced CT for detection and characterization of hepatocellular carcinoma: potential explanations for discrepant cases. Anticancer Res,2021,41(3):1451-1458. [9] 陈海琳,杨涛,周云.原发性肝癌患者双源CT全肝灌注成像特点及对TACE术后残余病灶的评估价值.实用肝脏病杂志,2024,27(5):769-772. [10] 中华人民共和国国家卫生健康委员会医政司.原发性肝癌诊疗指南(2024年版).中华肝脏病杂志,2024,32(7):581-630. [11] 郝永欣,孟祥安,骆允,等.超声造影与增强CT检查诊断小肝癌效能比较.实用肝脏病杂志,2024,27(1):88-91. [12] Peng Z, Fan W, Zhu B, et al. Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH). J Clin Oncol,2023,41(1):117-127. [13] Hong S, Kim JE, Cho JM,et al. Quantification of liver extracellular volume using dual-energy CT for ruling out high-risk varices in cirrhosis. Eur J Radiol,2022,148:110151. [14] 刘阳,李鸣鹤,孙羽凡.多层螺旋CT灌注成像参数与血清协同刺激分子B7家族3、甲胎蛋白异质体3的相关性及对肝细胞肝癌的诊断价值.中国医师进修杂志,2025,48(6):485-488. [15] Elebiyo TC, Rotimi D, Evbuomwan IO, et al. Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy. Cancer Treat Res Commun,2022,32:100620. [16] Xu D, Si GY, He QZ. Correlation analysis of multi-slice computed tomography (MSCT) findings, clinicopathological factors, and prognosis of gastric gastrointestinal stromal tumors. Transl Cancer Res,2020,9(3):1787-1794. [17] 林永祝,史红媛,穆西虎.双源CT肝动脉三期扫描和增强灌注扫描诊断肝硬化背景下小原发性肝癌价值研究.实用肝脏病杂志,2023,26(3):412-415. [18] Qi LW, Xie YF, Wang WN, et al. High microvessel and lymphatic vessel density predict poor prognosis in patients with esophageal squamous cell carcinoma. PeerJ,2024,12:e18080. [19] Mamdouh S, Soliman A, Khorshed F, et al. Glypican-3, vascular endothelial growth factor and Golgi protein-73 for differentiation between liver cirrhosis and hepatocellular carcinoma. Asian Pac J Cancer Prev,2023,24(2):497-507. [20] Yang Y, Fu N, Wang H, et al. Leukocytes infiltration correlates intratumoral microvessel density and influence overall and late-phase disease-free survival in hepatocellular carcinoma. Medicine (Baltimore),2021,100(48):e28135. |